Comparison of the effects of albumin and crystalloid on mortality among patients with septic shock
systematic review with meta-analysis and trial sequential analysis
Keywords:
Albumins, Crystalloid solutions, Mortality, Shock, septicAbstract
BACKGROUND: This study aimed to compare the effects on mortality of albumin and crystalloid, used for fluid resuscitation among adult patients with septic shock, through conducting a meta-analysis and trial sequential analysis (TSA).DESIGN AND SETTING: Meta-analysis and TSA conducted at Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China.METHODS: Data were collected from several major databases including MEDLINE, EMBASE, Clinical Trials.gov and Cochrane Central Register of Controlled Trials. Studies that compared the effects of albumin ther-apy versus crystalloid therapy on mortality among adult septic shock patients were eligible for inclusion in the analyses. The study name, year of publication, country of the trial, albumin concentration, type of crystalloid and all reported mortalities at different follow-up endpoints were extracted.RESULTS: Compared with crystalloid, albumin did not decrease all-cause mortality at the final follow-up. However, in TSA, the required information size was not achieved in all groups, which means that the effect size was not definitive and further RCTs are needed to confirm or deny these findingsCONCLUSIONS: Compared with crystalloid solutions, albumin was unable to decrease all-cause mortality. However, TSA indicated that these results could be false-negative. Additional randomized controlled trials are needed to clarify this discrepancy.
Downloads
References
Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-10. PMID: 26903338; doi: 10.1001/jama.2016.0287.
Asfar P, Meziani F, Hamel JF, et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014;370(17):1583-93. PMID: 24635770; doi: 10.1056/NEJMoa1312173.
Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369(9):840-51. PMID: 23984731; doi: 10.1056/NEJMra1208623.
Ospina-Tascon G, Neves AP, Occhipinti G, et al. Effects of fluids on microvascular perfusion in patients with severe sepsis. Intensive Care Med. 2010;36(6):949-55. PMID: 20221744; doi: 10.1007/s00134-010-1843-3.
Niemi TT, Miyashita R, Yamakage M. Colloid solutions: a clinical update. J Anesth. 2010;24(6):913-25. PMID: 20953964; doi: 10.1007/s00540-010-1034-y.
Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367(20):1901-11. PMID: 23075127; doi: 10.1056/NEJMoa1209759.
Guidet B, Martinet O, Boulain T, et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Crit Care. 2012;16(3):R94. PMID: 22624531; doi: 10.1186/cc11358.
Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med. 2012;367(2):124-
PMID: 22738085; doi: 10.1056/NEJMoa1204242.
McIntyre L, Fergusson DA, Rowe B, et al. The PRECISE RCT: evolution of an early septic shock fluid resuscitation trial. Transfus Med Rev. 2012;26(4): 333-41. PMID: 22222146; doi: 10.1016/j.tmrv.2011.11.003.
Zhong JZ, Wei D, Pan HF, et al. Colloid solutions for fluid resuscitation in patients with sepsis: systematic review of randomized controlled trials. J Emerg Med. 2013;45(4):485-95. PMID: 23932700; doi: 10.1016/j. jemermed.2013.05.018.
Jiang L, Jiang S, Zhang M, Zheng Z, Ma Y. Albumin versus other fluids for fluid resuscitation in patients with sepsis: a meta-analysis. PLOS One. 2014;9(12):e114666. PMID: 25474401; doi: 10.1371/journal. pone.0114666.
Ma PL, Peng XX, Du B, et al. Sources of heterogeneity in trials reporting hydroxyethyl starch 130/0.4 or 0.42 associated excess mortality in septic patients: A systematic review and meta-regression. Chin Med J (Engl). 2015;128(17):2374-82. PMID: 26315087; doi: 10.4103/0366-6999.163387.
Raghunathan K, Bonavia A, Nathanson BH, et al. Association between initial fluid choice and subsequent in-hospital mortality during the resuscitation of adults with septic shock. Anesthesiology. 2015; 123(6): 1385-93. PMID: 26414499; doi: 10.1097 /ALN. 0000000000000861.
Charpentier J, Mira JP, EARSS Study Group. Efficacy and tolerance of hyperoncotic albumin administration in septic shock patients: the EARSS study (Abstract). Intensive Care Med. 2011; 37(Suppl1):S115.
Caironi P, Tognoni G, Masson S, et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;370(15):1412-21. PMID: 24635772; doi: 10.1056/NEJMoa1305727.
Patel A, Laffan MA, Waheed U, Brett SJ. Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality. BMJ. 2014;349:g4561. PMID: 25099709; doi: 10.1136/bmj.g4561.
Xu JY, Chen QH, Xie JF, et al. Comparison of the effects of albumin and crystalloid on mortality in adult patients with severe sepsis and septic shock: a meta-analysis of randomized clinical trials. Crit Care. 2014;18(6):702. PMID: 25499187; doi: 10.1186/s13054-
- 0702-y.
Park C, Osawa E, Almeida J, et al. Lactated Ringer Versus Albumin in Early Sepsis Therapy (RASP) study: preliminary data of a randomized controlled trial. Crit Care. 2015;19(Suppl 1):P355. doi:10.1186/cc14435.
Rackow EC, Falk JL, Fein IA, et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Crit Care Med. 1983;11(11):839-50. PMID: 6194934.
Finfer S, Bellomo R, Boyce N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350(22):2247-56. PMID: 15163774; doi: 10.1056/NEJMoa040232.
Annane D, Siami S, Jaber S, et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA. 2013;310(17):1809-17. PMID: 24108515; doi: 10.1001/jama.2013.280502.
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336-41. PMID: 20171303; doi: 10.1016/j.ijsu.2010.02.007.
Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0 [updated March 2011]. Cochrane Collaborations; 2011. Available from: http://handbook-5-1.cochrane. org/. Accessed in 2018 (Jan 3).
Guyatt GH, Oxman AD, Vist GE, et al. GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-6. PMID: 18436948; doi: 10.1136/bmj.39489.470347.AD.
Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta-analysis. In: Borenstein M, Hedges LV, Higgins JPT, Rothstein HR, editors. Part 3: Fixed-effect versus random-effect models. West Sussex: John Wiley & Sons; 2009. p. 61-102. ISBN: 978-0-470-05724-7.
Wang JY, Xiao L, Chen J, et al. Potential effectiveness of traditional Chinese medicine for cardiac syndrome X (CSX): a systematic review and meta-analysis. BMC Complement Altern Med. 2013;13:62. PMID: 23497135; doi: 10.1186/1472-6882-13-62.
Wang HF, Yu JT, Tang SW, et al. Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson’s disease, Parkinson’s disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis. J Neurol Neurosurg Psychiatry. 2015;86(2):135-43. PMID: 24828899; doi: 10.1136/jnnp-2014-307659.
Thorlund K, Engstr OM, Wetterslev J, et al. User manual for trial sequential analysis (TSA). Copenhagen Trial Unit, Centre for Clinical Intervention Research; 2017. Available from http://www.ctu.dk/tsa/files/tsa_manual. pdf. Accessed in 2018 (Mar 9).
Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. Chichester: Wiley-Blackwell; 2008. ISBN: 978-0-470-69951-5.
Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol. 2008;61(1):64-75. PMID: 18083463; doi: 10.1016/j. jclinepi.2007.03.013.
Thorlund K, Devereaux PJ, Wetterslev J, et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? Int J Epidemiol. 2009;38(1):276-86. PMID: 18824467; doi: 10.1093/ije/dyn179.
